1. Home
  2. OSW vs ANIP Comparison

OSW vs ANIP Comparison

Compare OSW & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpaWorld Holdings Limited

OSW

OneSpaWorld Holdings Limited

HOLD

Current Price

$20.02

Market Cap

2.1B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$81.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSW
ANIP
Founded
2017
2001
Country
Bahamas
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OSW
ANIP
Price
$20.02
$81.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$24.33
$99.29
AVG Volume (30 Days)
478.6K
468.6K
Earning Date
10-29-2025
11-07-2025
Dividend Yield
1.00%
N/A
EPS Growth
40.79
N/A
EPS
0.70
1.67
Revenue
$936,080,000.00
$826,880,000.00
Revenue This Year
$8.68
$43.41
Revenue Next Year
$8.04
$9.66
P/E Ratio
$28.63
$48.82
Revenue Growth
7.27
48.87
52 Week Low
$14.21
$52.50
52 Week High
$23.49
$99.50

Technical Indicators

Market Signals
Indicator
OSW
ANIP
Relative Strength Index (RSI) 41.77 36.38
Support Level $19.60 $77.99
Resistance Level $20.86 $85.09
Average True Range (ATR) 0.71 2.61
MACD -0.02 0.19
Stochastic Oscillator 48.17 41.60

Price Performance

Historical Comparison
OSW
ANIP

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: